Lohitha Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.80 Cr
as on 05-07-2024
- Paid Up Capital ₹ 6.80 Cr
as on 05-07-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.39 Cr
as on 05-07-2024
- Satisfied Charges ₹ 4.68 M
as on 05-07-2024
- Revenue -29.52%
(FY 2023)
- Profit -102.32%
(FY 2023)
- Ebitda -41.39%
(FY 2023)
- Net Worth 5.09%
(FY 2023)
- Total Assets 5.91%
(FY 2023)
About Lohitha Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.80 Cr and a paid-up capital of Rs 6.80 Cr.
The company currently has active open charges totaling ₹13.39 Cr. The company has closed loans amounting to ₹4.68 M, as per Ministry of Corporate Affairs (MCA) records.
Bhetalam Jyostna and Bhetalam Bapiraju serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC071735
- Company No.
071735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Lohitha Life Sciences Private Limited offer?
Lohitha Life Sciences Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Organic Compounds, Piperidine, Organic Synthesizing Intermediates, API (Active Pharmaceutical Ingredients), Insecticides and Pesticides, Fungicides, Biocides, Bronopol.
Who are the key members and board of directors at Lohitha Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhetalam Jyostna  | Director | 20-Dec-2010 | Current |
| Bhetalam Bapiraju | Director | 20-Dec-2010 | Current |
Financial Performance of Lohitha Life Sciences.
Lohitha Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29.52% decrease. The company also saw a substantial fall in profitability, with a 102.32% decrease in profit. The company's net worth moved up by a moderate rise of 5.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lohitha Life Sciences?
In 2023, Lohitha Life Sciences had a promoter holding of 85.03% and a public holding of 14.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Dec 2023 | ₹1.00 Cr | Open |
Sidbi Creation Date: 11 Oct 2022 | ₹3.00 Cr | Open |
Others Creation Date: 29 Jun 2020 | ₹3.30 M | Open |
How Many Employees Work at Lohitha Life Sciences?
Lohitha Life Sciences has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lohitha Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lohitha Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
